Hemagglutinin (HA) 靶点蛋白|抗体药物|临床药物信息 - ACROBiosystems中国

> 【Hemagglutinin (HA)】

Hemagglutinin (HA)信息

英文名称：Influenza virus hemagglutinin glycoproteins
中文名称：血凝素
靶点别称：Hemagglutinin，HA，Hemagglutinin Glycoproteins， Influenza Virus

上市药物数量：0
临床药物数量：1
最高研发阶段：临床一期

Hemagglutinin (HA)分子别名

HA,Hemagglutinin

Hemagglutinin (HA)分子背景

Influenza, commonly known as 'the flu', is an infectious disease of birds and mammals caused by RNA viruses of the family Orthomyxoviridae, the influenza viruses. The virus is divided into three main types (Influenzavirus A, Influenzavirus B, and Influenzavirus C), which are distinguished by differences in two major internal proteins (hemagglutinin (HA) and neuraminidase (NA), which are the most important targets for the immune system. Hemagglutinin binds to the sialic acid-containing receptors on the surface of host cells during initial infection and at the end of an infectious cycle which makes it a great target for vaccine studies.

Hemagglutinin (HA)临床药物信息

英文名称	研发代码	研发阶段	公司	适应症	临床试验
Anti-influenza monoclonal antibody (AIMM Therapeutics)		临床一期	Aimm Therapeutics	流感病毒感染	详情

扫一扫关注微信公众号获取ACRO最新资讯

ACROBiosystems百普赛斯生物科技股份有限公司

全国：+86 400-682-2521

北京：010-53681107

上海：021-50850665

海外：+1 800-810-0816

邮箱：（产品订购）order.cn@acrobiosystems.com

邮箱：（技术支持）tech.cn@acrobiosystems.com

邮箱：（廉洁合规）lianjie@acrobiosystems.com

地址：北京经济技术开发区宏达北路8号5号楼4层

在线留言

发送

消息提示

请输入您的联系方式,再点击提交！